Clinical Study Shows MedCline™ as Effective Treatment for Silent Reflux

Share Article

The results of the most recent MedCline™ clinical trial, “Treatment of LPR with a Sleep Positioning Device,” were presented at the annual meeting of the American Association of Otolaryngology – Head and Neck Surgery showing MedCline™ to be an effective treatment for Silent Reflux/LPR.

The results of the most recent MedCline™ clinical trial, “Treatment of LPR with a Sleep Positioning Device,” were presented at the annual meeting of the American Association of Otolaryngology – Head and Neck Surgery, the world's largest organization of specialists who treat the ear, nose, throat and related structures of the head and neck. The study results show MedCline™ to be an effective treatment for laryngopharyngeal reflux (LPR), commonly referred to as Silent Reflux.

This study by Cleveland Clinic was the first to evaluate MedCline™ with this patient population. Silent Reflux/LPR occurs when stomach acid travels up to the throat causing symptoms, such as chronic cough, difficulty swallowing, asthma, sinusitis or a sore throat. Fifty percent of Silent Reflux/LPR patients do not experience heartburn or regurgitation as commonly experienced with Gastroesophageal Reflux Disease (GERD). Silent Reflux/LPR is commonly treated with higher doses of PPI medications for prolonged periods of time.

The study included patients diagnosed with Silent Reflux/LPR. Patients were instructed to sleep on MedCline™ for at least six hours per night for 28 consecutive nights in an at-home setting. Patients were instructed to maintain their current medication regime during the entire study. Symptom data was collected via two validated questionnaires: (1) Nocturnal GERD Symptom Severity and Impact Questionnaire (N-GSSIQ) and (2) Reflux Symptoms Index (RSI) survey. Both questionnaires were completed by patients upon enrollment, after night 14 and after night 28.

The results showed a significant reduction in scores across all measures using Medcline™:

  • 35% decrease in N-GSSIQ scores by night 14
  • 57% decrease in N-GSSIQ scores by night 28
  • 16% decrease in RSI scores by night 14
  • 51% decrease in RSI scores by night 28

The findings of this study are consistent with previous studies evaluating MedCline™ for nocturnal GERD patients but extend its possible applications as an effective treatment for Silent Reflux/LPR patients.

For more information about this and other MedCline™ clinical trial result, contact Aaron Clark at 858-605-1747.

About MedCline™
MedCline™ is a positional therapy device that provides at-home, on-demand relief of nocturnal acid reflux/GERD. By combining proper upper-body elevation with left-side lateral positioning, MedCline™ provides, clinically proven symptom relief, while protecting the esophagus from damaging esophageal acid. Medcline™ is a Class I Medical Device available by prescription only.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jeanna Sanchez
Visit website